A research team has developed a unique linker technology to connect a synthetic drug delivery vehicle referred to as a nucleic acid nanocapsule (NAN) with a new peptide cross-linker approach. The NAN enables both a small molecule drug and a nucleic acid — RNA or DNA — to be delivered to a cell. This combination generates a nanocapsule capable of shepherding genetic or pharmaceutical molecules to a target on or within a cell.

Via:: http://feeds.sciencedaily.com/~r/sciencedaily/matter_energy/nanotechnology/~3/QNgDuqSQWmY/171204105320.htm

Programmable drug delivery platform combats diseased cells at genetic level

Leave a Reply